Generic Name | Follitropin
Active Ingredient | Follitropin
US Brand Names | Gonal-f, Follistim, Menopur
Drug Category | Gynecology
Drug Class | Palliative treatment, Immunosuppressive therapy
Dosage Forms | Injection, powder for solution, solution, kit
Route of Administration | Intramuscular, Subcutaneous, Parenteral, Cutaneous
FDA Approval Status | FDA Approved (September 1997)

Follitropin: Overview

Follitropin is a Biologic and Hormone Modulator utilized to treat infertility in both women and men. It is a recombinant human follicle-stimulating hormone (FSH) produced through advanced genetic engineering, designed to stimulate the development of ovarian follicles or induce sperm production.

What Is Follitropin & How Does It Work?

Follitropin acts as a Targeted Therapy to replace or supplement natural follicle-stimulating hormone. At the cellular level, it binds to the FSH receptor, a G-coupled transmembrane receptor located on the granulosa cells of the ovaries and the Sertoli cells of the testes. This binding activates intracellular signaling pathways, specifically the PI3K and Akt pathways. In women, this stimulation promotes the growth and maturation of multiple ovarian follicles, which contain the eggs. In men, this same receptor activation induces and maintains spermatogenesis, the process of sperm production.

Is Follitropin FDA Approved?

Follitropin has been FDA approved since March 2004 for the treatment of specific infertility conditions. In the Gynecology department, reproductive endocrinologists prescribe this medication as a crucial component of assisted reproductive technology (ART) protocols and ovulation induction therapies.

What Is Follitropin Used For?

  • Stimulation of multiple follicles in women undergoing in vitro fertilization (IVF) or gamete intrafallopian transfer (GIFT).
  • Ovulation induction in women with primary ovarian failure or hypogonadotropic hypogonadism, often combined with human chorionic gonadotropin (hCG).
  • Induction of spermatogenesis in men diagnosed with hypogonadotropic hypogonadism.

Before Taking Follitropin: Contraindications & Precautions

Prior to initiating Follitropin therapy, a comprehensive medical evaluation is necessary to ensure safety and identify any conditions that might preclude its use.

Who Should Not Take Follitropin?

  • Women with primary ovarian failure (ovaries no longer function).
  • Individuals with uncontrolled thyroid or adrenal dysfunction.
  • Patients with active tumors of the hypothalamus or pituitary gland.
  • Women with abnormal vaginal bleeding of unknown cause.
  • Patients with ovarian cysts or enlargement not related to polycystic ovary syndrome (PCOS).

Follitropin: Pregnancy & Fertility

Follitropin is prescribed specifically to enhance fertility and assist in achieving pregnancy. However, it must not be used by women who are already pregnant, as there is no medical indication for its use during gestation. It is not known whether Follitropin passes into breast milk; therefore, its use in nursing mothers is generally not recommended unless clearly necessary. The primary objective of Follitropin therapy is the successful treatment of infertility.

Tell Your Doctor Before Taking Follitropin

  • If you have a history of blood clots or risk factors for thrombosis.
  • If you have been diagnosed with polycystic ovary syndrome (PCOS), as this significantly increases the risk of ovarian hyperstimulation syndrome (OHSS).
  • If you have a history of allergic reactions to gonadotropins or any components of the Follitropin formulation.

Follitropin: Dosage & Administration

Follitropin is administered as an injection, and the dosing is highly individualized based on the patient’s specific diagnosis, ovarian reserve, and response to treatment.

Standard Follitropin Dosing

  • For ovulation induction, a typical starting dose is 75 IU daily, which may be adjusted based on ultrasound and hormone monitoring.
  • For ART (like IVF), starting doses generally range from 150 IU to 225 IU daily, adjusted according to the ovarian response.
  • In men treated for hypogonadotropic hypogonadism, the dose is usually 150 IU three times a week, administered alongside hCG.

How Follitropin Is Administered

  • Follitropin is injected subcutaneously (under the skin) or intramuscularly, depending on the specific product formulation.
  • Many formulations come in pre-filled pens designed for convenient self-administration at home.
  • Patients should be carefully instructed by their healthcare team on the proper injection technique and the rotation of injection sites.

Follitropin: Clinical Efficacy & Research

Extensive clinical trials have established Follitropin as a highly effective treatment for infertility. In women undergoing ART, Follitropin successfully stimulates the development of multiple mature follicles, allowing for the retrieval of numerous eggs and increasing the chances of a successful pregnancy. In men with hypogonadotropic hypogonadism, long-term therapy with Follitropin and hCG has been shown to successfully induce spermatogenesis, resulting in the appearance of sperm in the ejaculate and enabling natural conception or conception via ART.

Follitropin: Side Effects & Safety Profile

BLACK BOX WARNING

This medication does not have an FDA Black Box Warning. However, the risk of severe Ovarian Hyperstimulation Syndrome (OHSS) is a critical concern that requires strict monitoring during therapy.

While Follitropin is effective, it carries the potential for side effects, some of which require careful medical management.

Common Follitropin Side Effects

  • Headache
  • Abdominal pain or pelvic discomfort
  • Injection site reactions (pain, redness, bruising)
  • Nausea
  • Breast tenderness

Serious Follitropin Adverse Events

  • Ovarian Hyperstimulation Syndrome (OHSS), a serious and potentially life-threatening condition involving fluid accumulation in the abdomen and chest.
  • Thromboembolic events (blood clots) in veins or arteries.
  • Ovarian torsion (twisting of the ovary), a medical emergency.
  • Multiple gestations (twins, triplets), which increase the risks associated with pregnancy.

Managing Follitropin Side Effects

Mild injection site reactions can be managed with cold compresses and rotating sites. If you experience severe abdominal pain, bloating, sudden weight gain, nausea, or shortness of breath, seek emergency medical care immediately, as these are symptoms of OHSS.

Follitropin: Interactions & What to Avoid

Certain medications or lifestyle factors can interact with Follitropin or affect the overall success of fertility treatments.

Follitropin: Interactions

  • Concurrent use of other ovulation-inducing agents (e.g., clomiphene citrate) may potentiate the follicular response, requiring careful dose adjustments.
  • There are no other known clinically significant drug-drug interactions, but full disclosure of all medications is essential.

Follitropin: Food & Alcohol

  • Maintain a balanced, healthy diet to support overall reproductive function.
  • Avoid excessive alcohol consumption and smoking, as these can significantly reduce fertility and lower the success rates of ART procedures.

Follitropin: Missed Dose, Overdose & Storage

Strict adherence to the dosing schedule and proper storage of the medication are crucial for the success of Follitropin therapy.

Missed Dose of Follitropin

If you miss a dose of Follitropin, contact your Gynecology clinic immediately for instructions. Do not inject a double dose to make up for a missed one, as precise hormone timing is necessary for proper follicle development.

Follitropin: Overdose & Emergency

While an acute overdose of Follitropin alone is rare, excessive stimulation can lead to severe OHSS. If an overdose is suspected or severe symptoms of OHSS occur, seek immediate emergency medical evaluation.

How to Store Follitropin

  • Storage requirements vary by product (e.g., Gonal-f, Follistim). Many require refrigeration before use and can be kept at room temperature for a limited time after opening.
  • Protect the medication from light and do not freeze.
  • Always follow the specific storage instructions provided with your prescribed brand of Follitropin.

Follitropin: Patient Management & Monitoring

Vigilant monitoring by a reproductive specialist is mandatory during treatment with Follitropin to ensure safety and optimize outcomes.

Tests Before Starting Follitropin

  • Comprehensive endocrine evaluation, including baseline FSH, LH, estradiol, and thyroid hormones.
  • Pelvic ultrasound to assess baseline ovarian status, antral follicle count, and rule out cysts.
  • Semen analysis for the male partner.

Monitoring During Follitropin Treatment

  • Frequent transvaginal ultrasounds to monitor the size and number of developing follicles.
  • Regular serum estradiol measurements to assess the ovarian response and adjust dosages.
  • Close monitoring for any signs or symptoms of OHSS.

Follitropin: Do’s and Don’ts

  • Do attend all scheduled monitoring appointments for ultrasounds and blood tests.
  • Do follow the exact injection instructions and schedule provided by your healthcare team.
  • Don’t adjust your dosage without explicit instructions from your physician.
  • Don’t engage in strenuous physical activity or heavy lifting if your ovaries become enlarged, to minimize the risk of ovarian torsion.

Frequently Asked Questions

What is Follitropin used for?

Follitropin is used to treat infertility by stimulating the ovaries to produce multiple eggs in women and by inducing sperm production in men.

How does Follitropin work?

It acts as a Hormone Modulator, replacing or supplementing natural FSH to stimulate follicle growth in the ovaries or spermatogenesis in the testes.

How is Follitropin administered?

It is administered via injection, usually subcutaneously (under the skin), and often using a pre-filled pen device for home use.

Can Follitropin cause multiple pregnancies?

Yes, because it stimulates the release of multiple eggs, fertility treatments involving Follitropin increase the chance of multiple pregnancies (twins or more).

What is OHSS and why is it important?

Ovarian Hyperstimulation Syndrome (OHSS) is a serious side effect where the ovaries swell and fluid leaks into the abdomen. It requires prompt medical attention.

How should I store Follitropin?

Storage varies by brand. Most require refrigeration but can be kept at room temperature for a specific period once opened. Always check the package insert.

Does Follitropin interact with other medications?

There are no major known drug interactions, but combining it with other fertility drugs requires careful monitoring by your specialist.

References

  • US Food and Drug Administration (FDA) Approved Labeling for Gonal-f / Follistim.
  • Drugs@FDA Index & Prescribing Information; Gonal-f / Follistim (Follitropin Alfa / Beta).
  • DrugBank Compound Summary & Pharmacological Classification; Follitropin (Accession Number DB00066).

The information provided is for educational and informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider at any hospital or any local clinic before starting or stopping any medication.